Meeting report: ninth and tenth workshops of the European Paediatric Network for Haemophilia Management (PedNet).

about

Meeting report: ninth and tenth workshops of the European Paediatric Network for Haemophilia Management (PedNet).

Item

http://www.wikidata.org/entity/Q36945968

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Meeting report: ninth and tent ...... emophilia Management (PedNet).

@en

type

Item

label

Meeting report: ninth and tent ...... emophilia Management (PedNet).

@en

prefLabel

Meeting report: ninth and tent ...... emophilia Management (PedNet).

@en

P1476

Meeting report: ninth and tent ...... emophilia Management (PedNet).

@en

P2093

A E Thomas

http://www.w3.org/2001/XMLSchema#string

European Paediatric Network for Haemophilia Management (PedNet)

http://www.w3.org/2001/XMLSchema#string

K Kurnik

http://www.w3.org/2001/XMLSchema#string

P2860

Incidence of inhibitors in haemophilia A patients--a review of recent studies of recombinant and plasma-derived factor VIII concentrates.

First and second generation recombinant factor VIII concentrates in previously untreated patients: recovery, safety, efficacy, and inhibitor development.

Haemophilia and the newborn.

Cellular and genetic therapies for haemophilia.

Factor VIII ectopically targeted to platelets is therapeutic in hemophilia A with high-titer inhibitory antibodies.

Efficacy and safety of adeno-associated viral vectors based on serotype 8 and 9 vs. lentiviral vectors for hemophilia B gene therapy.

Canadian multi-institutional survey of immune tolerance therapy (ITT) -- experience with the use of recombinant factor VIII for ITT.

Current co-ordinated activities of the PEDNET (European Paediatric Network for Haemophilia Management).

Thrombin generation in factor VIII-depleted neonatal plasma: nearly normal because of physiologically low antithrombin and tissue factor pathway inhibitor.

Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin.

P304

658-662

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2516.2007.01491.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2007-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

227721508

http://www.w3.org/2001/XMLSchema#string

P698

17880459

http://www.w3.org/2001/XMLSchema#string

P921

hemophilia

workshop